Ontology highlight
ABSTRACT: Background
Since its localization to the NKX2-1 gene in 2002, the phenotype of the disorder historically called "benign hereditary chorea" has been expanding beyond chorea.Methods
The phenomenology of movement disorders and other symptomatology associated with mutations in NKX2-1 were characterized after a detailed evaluation of consecutive patients evaluated in our clinic over the past 3 years.Results
We studied 5 patients (3 females), ages 2 to 31 years, with confirmed pathogenic variants in NKX2-1. All patients exhibited chorea, gross motor delay, and gait impairment. Other symptoms included neonatal respiratory failure (n?=?4), cognitive deficits (n?=?3), hypothyroidism (n?=?4), joint laxity (n?=?2), myoclonus (n?=?1), hypotonia (n?=?3), and seizures (n?=?1). Chorea often proved refractory to medical therapies.Conclusions
The phenotype associated with pathogenic variants in NKX2-1 frequently includes disabling and often medically refractory neurological and non-neurological abnormalities. We therefore suggest that the term benign hereditary chorea be abandoned in favor of its genetic designation as NKX2-1-related disorder.
SUBMITTER: Parnes M
PROVIDER: S-EPMC6335533 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature
Movement disorders clinical practice 20181109 1
<h4>Background</h4>Since its localization to the <i>NKX2-1</i> gene in 2002, the phenotype of the disorder historically called "benign hereditary chorea" has been expanding beyond chorea.<h4>Methods</h4>The phenomenology of movement disorders and other symptomatology associated with mutations in <i>NKX2-1</i> were characterized after a detailed evaluation of consecutive patients evaluated in our clinic over the past 3 years.<h4>Results</h4>We studied 5 patients (3 females), ages 2 to 31 years, w ...[more]